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samples were collected from the tail on day 1 and 3, while 
retro-orbital sampling was used on day 5. The samples 
were analysed using gas chromatography time-of-flight 
mass spectrometry (GC TOF-MS).
Results The thawed plasma samples were found to be 
characterized by higher levels of amino acids, fatty acids, 
glycerol metabolites and purine and pyrimidine metabo-
lites as a result of protein degradation, cell degradation and 
increased phospholipase activity. The consensus profile 
was thereafter compared to the previously published study 
comparing thawing profiles of tissue samples from gut, kid-
ney, liver, muscle and pancreas.
Conclusions The comparison between thawed organ sam-
ples and thawed plasma samples indicate that the organ 
samples are more sensitive to thawing, however thawing 
still affected all investigated sample types.
Keywords Mouse · Metabolomics · Plasma · Multi-
organ · Freeze–thaw cycle · OPLS-DA
1 Introduction
Metabolomic studies involve several steps starting from 
the hypothesis or study design and resulting in a biologi-
cal interpretation (Brown et  al. 2005; Krastanov 2010). It 
is essential to use a carefully planned experimental design, 
since metabolomics studies are complicated by the high 
temporal and spatial variability that the metabolites demon-
strate e.g. physical properties, chemical properties and con-
centration range (Korn et al. 2007). The experiments must 
rest on a well thought-out foundation, making the design 
unfold in a proper fashion. The pipeline for a metabolomics 
approach often involves experimental planning, sampling, 
storage, pre-treatment, chemical analysis, data processing, 
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multivariate data analysis, validation, and biological inter-
pretation. The outcome of the study as well as the quality 
of the results is highly dependent on how well each step 
of the pipeline is executed. In order to obtain reliable and 
reproducible results, standardised protocols have been pro-
posed (Lindon et  al. 2005). However, steps that are often 
overlooked include the experimental planning, sampling 
and transportation of samples and the effects that these 
have on the final results and the biological interpretation.
Blood samples are commonly used in metabolomics 
studies. Blood samples mainly contains endogenous metab-
olites, but also food and drug metabolites, so called exog-
enous metabolites (Bouatra et  al. 2013). Nonetheless, the 
sampling can easily affect the metabolome. The metabo-
lite concentration in blood can be affected by the time the 
sample spends in room temperature, storage conditions as 
the time left to stand at room temperature prior to centrifu-
gation (Yin et al. 2015). In order to overcome these prob-
lems it is essential to follow a standard operating procedure 
(SOP), such as the one utilized in the present study (Hol-
land et al. 2005).
The stability and reproducibility of metabolite meas-
urements as a response to shipment has previously been 
investigated with a focus on a small number of metabo-
lites, in whole blood. The investigated metabolites include 
e.g. amino acids (Davis et  al. 2009), cholesterol (Giltay 
et al. 2003; Clark et al. 2003; Key et al. 1996), fatty acids 
(Eijsden et  al. 2005), glucose (Bruns and Knowler 2009), 
lipids (Key et  al. 1996; Eijsden et  al. 2005) and vitamins 
(Key et al. 1996). In addition, a study has been performed, 
addressing the reproducibility of targeted metabolomics 
using human plasma and serum samples from different 
time-points (Breier et al. 2014). The focus of these studies 
have been to identify alterations associated with repeated 
freeze–thaw cycles as well as different shipment conditions.
In a previous study the authors studied metabolic altera-
tions associated with thawing of multiple organ samples, 
including gut, kidney, liver, muscle and pancreas (Torell 
et al. 2015). It was found that the metabolite levels in tissue 
samples reacted highly similar to thawing. In the present 
study, the authors present the metabolic changes observed 
as a response to thawing of plasma samples obtained from 
the same mice on three different days of experiments. Since 
the results of thawing studies have previously been incon-
clusive, more work is needed in this area. The aim of this 
study was to investigate differences in thawing sensitivity 
and metabolite stability, between different sample types 
(i.e. gut, kidney, liver, muscle, pancreas and plasma). This 
was achieved by performing a comparative study between 
the consensus plasma profile and the thawing effects on 
multi-organ samples. Initially, the metabolic profile associ-
ated with changes observed in plasma samples, as a result 
of thawing, was obtained. Thereafter, the differences and 
similarities between plasma and organ samples, in response 
to thawing was evaluated.
2  Materials and methods
2.1  Samples
Eight-month-old wild-type male mice of the mixed back-
ground 129sv x C57Bl/6N (n = 15) were individually 
placed in metabolic cages (Metabolic cage for mice, Tec-
niplast™, UK), with access to food [ref A04-10 in pow-
der, Scientific animal food & engineering (SAFE), France] 
and water. The animals were kept 5 days in the metabolic 
cages, 2 days as an adaptation period and 3 days of experi-
ment. Each experimental day, animals were weighed. Food 
and water intake, urine volume and fecal weight for each 
mouse were recorded. Urine and feces were collected every 
24 h, and frozen at −80 °C for storage until analysis. After 
4 h fasting, 50 µL of blood from the tail was recovered in 
heparin tubes (Microvette CB300 LH, Sarstedt, Germany). 
Plasma was obtained from the blood sample by centrifuga-
tion (2000 rpm, 5 min at 20 °C), and frozen at −80 °C. The 
fifth day of experiment, animals were anesthetized with a 
ketamine and xylazine solution by intraperitoneal injec-
tion, a blood sample was obtained by retro-orbital bleeding 
performed with a heparinized Pasteur pipette, and plasma 
was prepared as described above. Animals were killed by 
cervical dislocation. Animal experiments were conducted 
in accordance with French and European ethical legal 
guidelines and the local ethical committee for animal care 
(Comité d’éthique en expérimentation animale Charles 
Darwin No. 5, approval number No. 01508.01) specifically 
approved this study.
All of the samples were placed on blocks of dry ice 
(3  kg) in two separate, sealed, styrofoam boxes. One box 
was shipped for 24 h, in which all the samples arrived to 
the destination frozen. In contrast, the second box was 
shipped for a total of 72 h, after which all samples arrived 
to the destination thawed. The organ samples were divided 
into two separate groups, based on the shipment time. 
No significant changes in metabolite concentration have 
been observed during 24  h shipment (Breier et  al. 2014). 
Therefore, the groups have been referred to as ‘frozen’ 
and ‘thawed’ (n1 = 8 × 3 and n2 = 7 × 3, respectively). All 
samples were stored at −80 °C until metabolic profiling 
analysis.
2.2  Metabolomic analysis
Metabolites were extracted from 50  µL plasma ali-
quots according to the method described by A et  al. 
(2005). The samples were then analysed using gas 
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chromatography time-of-flight mass spectrometry (GC 
TOF-MS) and detected metabolites were identified and 
quantified as described by Jonsson et al. (2005) Complete 
method description is available as supplementary data. 
As a means of quality control to account for any analyti-
cal variation and to test the reproducibility of the method, 
several samples were performed in triplicates. In order to 
account for any instrumental variation and to monitor run 
order effects, the triplicates were separated throughout the 
run list during the GC–MS analysis.
2.3  Data analysis
Variance was checked by means of F-test. p values were 
calculated by applying Student’s t test for samples of equal 
variance or unequal variance, depending on the result of the 
F-test. The t tests were then corrected for multiple testing 
using Benjamini–Hochberg FDR method (Benjamini and 
Hochberg 1995). The false discovery rate was set to be 5%.
Person correlation coefficients were calculated based 
on the p(corr)-loading values from OPLS-DA frozen ver-
sus thawed models to measure how well the thawing pro-
files correlated. The results of Pearson correlation range 
between −1 and 1, where high correlation is indicated if 
the absolute value is between ± 0.5 to ± 1, medium correla-
tion range between ± 0.3 to ± 0.5 and values between 0 and 
± 0.3 indicate low correlation.
Multivariate analysis was performed on unit variance 
scaled data using SIMCA, version 14.0 (Umetrics AB, 
Umeå, Sweden). Multivariate data analysis was based 
on principal component analysis (PCA) (Jackson 1991), 
orthogonal projection to latent structures (OPLS) (Trygg 
and Wold 2002) and orthogonal projection to latent struc-
tures discriminant analysis (OPLS-DA) (Bylesjö et  al. 
2006). Two components were calculated for all types of 
models. As a part of quality control the data was examined 
by means of run order control and quality control of tripli-
cates. The triplicates and duplicates were in close proxim-
ity, in the same quadrant in the PCA score scatter plot, i.e. 
displaying similar characteristics. Therefore, an average of 
each of the replicates was used for further data analysis.
PCA is an unsupervised multivariate technique where 
the variation is summarized into a smaller number of latent 
variables, so called principal components. The latent vari-
ables are used to visualize the observations (samples). 
Thereby, the relationship between observations that are 
characterized by many variables can be visualized in low 
dimensional plots (Wold et al. 1987).
OPLS is a supervised method which finds the vari-
ation in X (the metabolic data) that is correlated to Y (in 
our study, the run order). OPLS summarizes the systematic 
variation in X that is correlated to Y in one component, 
called the predictive component (t1).Simultaneously it also 
finds the systematic variation in X that is uncorrelated to 
Y, and places it in other components, called orthogonal 
components (to) (Trygg and Wold 2002). An OPLS model 
was calculated in order to assess the size of the run order 
effects.
OPLS-DA is an extension of OPLS. OPLS-DA is a 
supervised method which finds the variation in X (the met-
abolic data) that is correlated to Y (in our study, dummy 
variables representing frozen and thawed samples). In case 
of a two-class problem, OPLS-DA summarizes all the rel-
evant variation in one predictive component (t1), while the 
systematic variation in X that is uncorrelated to Y, is placed 
in one orthogonal component (to) (Bylesjö et  al. 2006). 
Variable significance was determined by interpreting the 
correlation scaled loading values (p(corr)), from the OPLS-
DA model, together with the 95% confidence intervals cal-
culated using jack-knifing (derived by seven-fold internal 
cross-validation). ANOVA of the cross-validated residuals 
(CV-ANOVA) was used to assess the significance of the 
OPLS-DA models (Eriksson et al. 2008).
The shared and unique structure (SUS) plot is produced 
by plotting the predictive components (p(corr)) from two 
different models, against one another. The resulting plot 
displays both shared and unique features for these two 
models. The shared features will be found in the diagonal 
and unique features in the areas close to the x- and y-axis. 
Hence, the SUS-plot can be used to find metabolites that 
vary in the same direction in both models, as well as 
metabolites that differ between the two models (Eriksson 
et al. 2013).
3  Results
3.1  Quality control
The metabolomic analysis resulted in the detection of 159 
metabolites, out of which 46 could be positively identified 
using our in-house libraries. The multivariate data analy-
sis was performed using the identified metabolites only. 
Initially, the samples that had been analysed in triplicates 
were evaluated using PCA. The multivariate data analysis 
found each set of triplicates to be clustered together in the 
score plot, confirming high reproducibility of the method. 
The run order effects were analysed by creating an OPLS 
model using the run order as the response variable. The run 
order analysis showed that no severe run order effects could 
be found (the predictive component was 0.07).
3.2  Frozen versus thawed plasma samples
The eight samples from each time point that arrived fro-
zen were initially compared to the seven samples from 
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each time point that arrived thawed. In order to get an over-
view of these samples a PCA model was calculated, which 
resulted in a two component model where  R2X = 0.43. The 
PCA score plot can be found in the supplementary data.
On the fifth day, the mice were given anaesthesia. The 
animals were anaesthetised with Ketamine/Xylazine, which 
can have profound effects on the global metabolic profiles 
(Overmyer et al. 2015). It should be noted that on day 1 and 
day 3, the blood was drawn from the tail which resulted in 
a mix of venous and arterial blood whereas the sinus retro-
orbital sampling procedure used on day 5 gave only venous 
blood. This may have introduced a difference in metabolic 
composition between the different sampling days (Hoff and 
Rlagt 2000). Therefore, the samples from the fifth day were 
investigated separately. This was performed in order to 
assess the similarities and dissimilarities between the thaw-
ing of plasma samples where blood was drawn from the 
tail, without anaesthesia, and plasma samples drawn from 
the eye, where anaesthesia was used.
3.2.1  Frozen versus thawed plasma samples from day 1 
and 3
In order to obtain an overview of the thawed and frozen 
samples from day 1 and 3, a new PCA model was calcu-
lated for the samples from day 1 and day 3. The two com-
ponents explained 25 and 15% of the variation, respec-
tively. The first component explained approximately the 
thawed and frozen plasma samples from day 1 and 3. The 
score scatterplot can be seen in Fig. 1.
Thereafter, OPLS-DA models were calculated in order 
to compare thawed and frozen samples from day 1 and day 
3, see Table 1.
When comparing the metabolic pattern of frozen and 
thawed samples, 34 out of the 46 identified metabolites 
were found to have the same type of response to thawing, 
on day 1 and day 3. The statistical significance of these 
changes were calculated using t tests. The p values were 
then compared to the critical value, calculated using Ben-
jamini–Hochberg FDR method and p values below 0.0087 
were found to be significant. Out of the 34 that displayed a 
similar response on both days, 11 were found to display sta-
tistically significant differences between frozen and thawed 
samples. The p values are available as supplementary data. 
The differences between frozen and thawed plasma samples 
from day 1 and day 3 have been summarized in Fig. 2.
Box plots showing the differences, in relative metabo-
lite concentration, between the thawed and frozen samples 
from day 1, day 3 and day 5 are available as supplementary 
data.
3.2.2  Frozen versus thawed plasma samples from day 5
The samples were obtained by retro-orbital bleeding, on the 
fifth day of the experiment. In addition, the mice were anes-
thetized with a ketamine and xylazine solution by intraperi-
toneal injection. Initially, a two component PCA model was 
calculated  (R2X = 0.50). Thereafter, an OPLS-DA model 
Fig. 1  PCA score plot with frozen and thawed samples from day 1 
and day 3. The two components explained 25 and 15% of the vari-
ation, respectively. The first component explained approximately 
the thawed and frozen plasma samples. There was a tendency for 
the thawed samples to end up on the left-hand side in the score plot, 
while the frozen samples had a tendency to end up on the right-hand 
side. The blue and green spots represent the thawed samples (T) and 
the frozen samples (F), respectively. Samples from day 1 are rep-
resented by circles and samples from day 3 are represented by dia-
monds
Table 1  OPLS-DA models for 
frozen versus thawed plasma 
samples
Eight samples from each time-point arrived frozen, while seven from each time-point arrived thawed
A number of components, N number of samples that the model is based on, R2 “goodness of fit” parameter 
that shows how well the model describes the variation in the data.  R2X,  R2Y are the cumulative variations 
explained in the metabolite and class-variable data respectively, Q2Y “goodness of prediction” parameter 
and is the cross-validated prediction estimate of class separation that shows how well samples are predicted 
by the model
a p values were obtained using CV-ANOVA in SIMCA 14.0
Name Type A N R2X R2Y Q2Y p  valuea
Frozen versus thawed day 1 OPLS-DA 1 + 1 + 0 15 0.48 0.92 0.70 0.01
Frozen versus thawed day 3 OPLS-DA 1 + 1 + 0 15 0.46 0.95 0.80 0.002
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was calculated for the fifth day. The 1 + 1 + 0 component 
model had  R2X = 0.45,  R2Y = 0.89 and  Q2 = 0.55.
For samples from day 5, two metabolites were found to 
have a statistically significant difference between the frozen 
and thawed samples. Samples from day 5 displayed signifi-
cantly lower concentrations of cysteine (p value = 2.2E−06) 
and cystine (p value = 1.2E−07). This was also observed in 
samples from day 1 and day 3. The complete table contain-
ing the statistically significant metabolites, is available as 
supplementary data. The overall metabolic pattern related 
to thawing was highly similar for samples from all 3 days, 
even though the number of statistically significant metabo-
lites was lower in samples from day 5. By comparing all 
3 days, it was found that the levels of 30 out of the 46 iden-
tified metabolites were found to increase or decrease on all 
3 days, as a response to thawing.
In order to assess the similarities between the thawing-
profiles, from day 1, 3 and 5, Pearson correlation coeffi-
cient were calculated. The Pearson correlation coefficient 
were calculated based on the first p(corr)-loading obtained 
from the OPLS-DA models. Pearson correlation coefficient 
for Day 1 and 3 was high (0.60), the same was true for the 
Pearson correlation coefficient for Day 1 and 5 as well as 
Day 3 and 5 (0.70 and 0.58, respectively). A figure summa-
rizing the comparisons of the thawed and frozen samples 
from day 1, 3 and 5 is available as supplementary data.
3.3  Comparison between thawing plasma and organ 
samples
It was decided to use the thawing plasma profile from day 
5 and compare it to the previously published organ data 
(Torell et al. 2015). The samples from day 5 were selected 
since the organ and plasma samples were harvested on day 
5 after the mice had been exposed to anaesthesia (ketamine 
and xylazine solution). The organs and plasma had 35 iden-
tified metabolites in common. The p(corr) values from the 
OPLS-DA models, calculated to find metabolites discrimi-
nating between thawed from frozen samples, were used to 
create SUS-plots. The SUS-plots were created in order to 
identify the metabolites that were deviating between the 
thawed plasma day 5 and the other thawed organs (gut, kid-
ney, liver, muscle and pancreas) as well as plasma day 1, 
see Fig. 3.
4  Discussion
One of the aims of this study was to present a metabolic 
pattern associated with changes observed in the thawing 
of plasma samples. This was performed by constructing a 
type of consensus pattern for samples obtained from three 
different days. It should be noted that on day 1 and day 3, 
Fig. 2  Metabolite differences between frozen and thawed plasma 
samples. The metabolites in the left-hand column were found at 
higher levels in the frozen samples whereas the metabolites in the 
right-hand column (with a positive p(corr)-loading value) were higher 
in the thawed samples. Asterisks indicated the number of days that 
the difference between frozen and thawed were statistically significant 
(one asterisk represent that the difference was statistically significant 
one day, two asterisk showed that the difference between frozen and 
thawed samples was statistically significant on both days). Abbrevia-
tions used in the legend: A amine, AA amino acid, AK amino ketone, 
CHO carbohydrate, I inorganic acid, K ketone, L lipid constituent, P 
polyol, PU purine, PY pyrimidine and S sterol
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the blood was drawn from the tail which resulted in a mix 
of venous and arterial blood whereas the sinus retro-orbital 
sampling procedure used on day 5 gave only venous blood. 
This may introduce a difference in metabolic composition 
between the different sampling days (Hoff and Rlagt 2000). 
Ketamine has previously been shown to reduce the serum 
concentration of metabolites involved in glycolysis, TCA 
cycle, as well as the serum concentration of nucleosides 
(Overmyer et al. 2015). In the present study, the differences 
were mainly related to amino acids. However, it is impossi-
ble to distinguish the source of the discrepancies as there is 
a confounding pattern associated with the sampling site as 
well as anaesthesia. Therefore, the multivariate data analy-
sis of samples from day 5 were performed separately.
Fig. 3  SUS plots comparing plasma day 5 and organs (gut, kidney, 
liver, muscle and pancreas) and plasma day 1. The p(corr) for plasma 
was plotted against the p(corr) for each of the investigated organs 
(gut, kidney, liver and pancreas). This resulted in six separate SUS-
plots where the metabolites responsible for the deviating metabolic 
pattern observed in the thawed plasma samples could be identified. 
The deviating metabolites have been named in each of the SUS-plots. 
Leu leucine, Phe phenylalanine, Thr threonine and Trp tryptophan
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The thawed plasma samples were found to be charac-
terized by higher concentrations of creatinine, glycerol, 
glycerol-3-phosphate, methionine, ornithine, threonine, 
uracil, urea and uric acid as well as lower concentrations 
of cysteine and cystine. The samples from day 1 and day 3 
displayed stronger discriminations, in the change of metab-
olite levels, between thawed and frozen samples. Samples 
from day 5 displayed similar, yet not identical, differences 
between thawed and frozen samples compared to day 1 and 
day 3. Differences in response to thawing, between samples 
from day 1 and day 3 compared to day 5 could have been 
related to the anaesthesia or sampling site, but it might also 
have been due to other confounding factors.
In the present study, higher concentrations of most 
amino acids, fatty acids, purines and pyrimidines as well 
as metabolites involved in glycerol metabolism, were 
observed in the thawed samples compared to the frozen 
ones. This corresponds well to previous studies whereby 
ornithine, proline, and threonine (Davis et al. 2009; Breier 
et al. 2014), methionine (Breier et al. 2014), pyroglutamic 
acid (Hirayama et  al. 2015) hexadecanoic acid (C16:0) 
stearic acid (C18:0) (Eijsden et al. 2005; Breier et al. 2014), 
urea (Heins et  al. 1995), uric acid (Holland et  al. 2005; 
Pinto et al. 2014) as well as creatinine (Clark et al. 2003) 
have been found in higher concentrations, while cysteine 
(Hirayama et  al. 2015) has been found in lower concen-
trations, in thawed blood samples. In the present study, 
metabolites involved in glycerol metabolism (glycerol, 
glycerol-3-phospahte and glyceric acid) were all observed 
in higher concentrations in the thawed plasma samples. 
To the authors’ knowledge, the thawing response of these 
metabolites have not been studied utilizing a metabolomics 
approach. The concentration of glycerol and glycerol-
3-phosphate was significantly higher, which could poten-
tially be linked to lipolysis (Parasuraman et  al. 2010). 
While low levels of 3-hydroxybutyric acid, could be the 
result of the decreased fatty acid oxidation (Gomez-Cabrero 
et al. 2014). The increased concentration of the majority of 
amino acids implied that there was ongoing protein degra-
dation, e.g. enzymatic catabolism, in the thawed samples. 
The increased fatty acid concentration was a clear sign of 
cell membrane degradation and triaglycerol degradation 
that occur after repeated freeze/thaw cycles (Steponkus and 
Lynch 1989).
The major goal with this study was to make a compara-
tive study between the obtained consensus plasma profile 
and the previously published thawing effects on multi-
organ samples (Torell et  al. 2015), in order to evaluate 
the differences and similarities between plasma and organ 
samples from gut, kidney, liver, muscle and pancreas, in 
response to thawing.
The Pearson correlation coefficients indicated that the 
difference between frozen and thawed plasma samples were 
highly conserved, independent of different sampling days. 
Even though the differences between thawed and frozen 
plasma samples were much weaker (i.e. displayed fewer 
statistically significant differences between thawed and 
frozen samples and with a lower  Q2 value for the OPLS-
DA model for thawed versus frozen samples) in day 5, they 
still displayed similar characteristics. Samples from day 5 
were obtained after the mice had been anesthetized with a 
ketamine and xylazine solution by intraperitoneal injection. 
This was performed in order to harvest the organs. There-
fore, the samples from day 5 were used for the comparison 
between thawed plasma and organs.
Out of the 35 common metabolites identified in both 
plasma and organs, 13 were found to vary in a similar pat-
tern in thawed plasma from day 5 and all thawed organ 
samples. The similarities between thawed plasma and all 
of the thawed organ samples included higher concentration 
of amino acids (alanine, aspartic acid, glutamine, lysine, 
ornithine, serine and tyrosine), carbohydrates (ribose and 
glucose) and fatty acids (hexadecanoic acid, 9-(Z)-hexade-
cenoic acid, linoleic acid and oleic acid). Indicating that the 
overall trends can be associated with the ongoing protein 
and cell degradation, observed in the thawed samples from 
both plasma and organs.
The majority of the differences, associated with the 
metabolic changes between thawed plasma and thawed 
organs were fairly similar since the organs’ response to 
thawing was highly similar, especially with regards to the 
concentrations of amino acids, carbohydrates and fatty 
acids (Torell et  al. 2015). The SUS-plots revealed that 
one of the major differences between the thawed organ 
samples and plasma samples were the concentrations of 
branched chain amino acids (BCAA; leucine and valine), 
threonine and aromatic amino acids (AAA; tryptophan 
and phenylalanine). These metabolites were shown to 
increase significantly in all of the investigated organs, in 
response to thawing, while only slightly or no increased 
could be observed in thawed plasma samples. By com-
paring the thawed plasma samples from all 3  days, glu-
tamine, glycine, isoleucine, leucine, taurine and valine 
were found to be stable in the thawed plasma samples. 
Breier et  al. have found glycine and valine to be stable, 
while they found isoleucine and leucine to increase, 
during 24  h plasma shipment simulations at RT (Breier 
et  al. 2014). Yang et  al. have shown that nine amino 
acids including BCAAs were stable for 24  h at 37 °C, 
using rat plasma (Yang et  al. 2013). In addition, Davis 
et al. found glutamine and valine to be stable while they 
found glycine, isoleucine, leucine and taurine to increase, 
in whole blood left at RT for 24  h (Davis et  al. 2009). 
The reason for these discrepancies are not fully under-
stood. However, the studies use different sample types as 
well as different methods for amino acids quantification, 
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introducing several confounding factors. The cystine con-
centration was lower in the thawed plasma samples, while 
all of the thawed organs samples displayed higher cystine 
concentration. The thawed gut and liver samples also dis-
played high concentrations of cysteine, while the cysteine 
concentration in pancreas was found not to differ between 
thawed and frozen samples and was significantly lower in 
thawed plasma samples. This showed that the proteino-
genic amino acids increased to an even greater magnitude 
in the thawed organ samples than in the thawed plasma 
samples. One can hypothesize that the availability of 
enzymes might be one contributing factor or that some 
of the enzymes involved in the biodegradation of amino 
acids are more temperature persistent in plasma com-
pared to organ samples. On the other hand, this could be 
associated with physiological differences between organ 
samples and blood samples e.g. albumin.
The unique features of plasma in comparison to organ 
samples comprised of high concentrations of pyroglutamic 
acid and low concentrations of 3-hydroxybutyric acid. 
The concentrations of pyroglutamic acid were shown not 
to change as a response to thawing, in the majority of the 
organ samples, with the exception of the thawed kidney 
samples, where the pyroglutamic acid concentration was 
high. All of the organ samples displayed negligible altera-
tions in 3-hydroxybutyric acid concentration, as a response 
to thawing. The reason for the discrepancies between 
thawed plasma and organs are not yet fully understood, 
but might be related to densities of the samples as well as 
enzyme availability and sample contents.
TCA cycle intermediates (citric acid, fumaric acid and 
malic acid) were found to be stable in the thawed plasma 
samples, from all 3 days. The concentration of citric acid 
was found to be higher in thawed kidney and pancreas 
samples. The concentration of fumaric acid was strongly 
increased in the thawed kidney, liver and muscle samples 
as a response to thawing. While the concentration of malic 
acid was found to be higher in thawed liver and muscle 
samples, but also lower in thawed gut and pancreas sam-
ples. The biochemical reactions that constitute the TCA 
cycle are steps in the cellular energy metabolism. The con-
centration of the various TCA intermediates were very var-
iable both within sample type, on an individual level, and 
between sample types on an organ level. One reason may 
be that TCA intermediates are highly interchangeable and 
also work as inhibitors for enzymes interconverting them. 
High concentrations of TCA intermediates can potentially 
be explained by the fact that the TCA cycle intermediates 
have a tendency to leak out of cells with a damaged cell 
membrane (Sellick et al. 2011). Low concentrations on the 
other hand, may be explained by the utilization of TCA 
cycle intermediates in biochemical processes associated 
with the ongoing degradation.
Glycerol-3-phosphate was found in higher concentra-
tions in the thawed plasma samples, while the thawed 
kidney and muscle samples displayed markedly lower 
concentrations of this metabolite. The reason could be 
that triaglycerols were hydrolysed in the thawed plasma 
samples, resulting in increased levels of fatty acid and 
glycerol-3-phosphate. The majority of the fatty acids 
were found to decrease in response to thawing, in both 
plasma and the investigated organs, with the exception 
of the stearic acid concentration in muscle and pancreas, 
which was not affected by thawing.
The thawed organ samples, especially gut and kid-
ney, were characterized by declining cholesterol con-
centrations, while the thawed plasma samples displayed 
no significant alteration in cholesterol concentrations, in 
response to thawing. This indicated that lipid transfer or 
structural changes of lipoproteins occurred during thaw-
ing of the organ samples. The importance of reliable 
measurements of plasma cholesterol is evident since it 
is widely used for clinical purposes. The present study 
showed that cholesterol is fairly stable in plasma, but not 
in organ samples. The stability of cholesterol in blood 
samples has been debated, contradictory results have 
been found when investigating the effect of freeze–thaw 
cycles on the cholesterol concentration. The cholesterol 
concentration has been found to increase (Cuhadar et al. 
2013), decrease (Zivkovic et al. 2009) and remain stable 
(Comstock et al. 2008; Kronenberg et al. 1994).
Several of the differences in response to thawing, were 
unique for individual organ types. For example, the SUS 
plot for plasma and kidney revealed that the kidney sam-
ples responded to thawing with decreased concentrations 
of lactic acid, while the concentration of lactic acid in 
plasma did not differ between thawed and frozen sam-
ples. This could potentially be explained by the fact that 
the kidneys and the liver are the major organs involved 
in lactate metabolism (Bellomo 2002). Indicating that 
the thawed kidney samples displayed systematic changes 
in lactate metabolism. In addition, myo-inositol and tau-
rine concentrations were found to increase in plasma as a 
response to thawing while the thawed kidney samples dis-
played decreased concentration of these metabolites. Tau-
rine and myo-inositol function as osmolytes in the kid-
neys and have been found to co-ordinately respond to aid 
in cellular protection, which may explain the high con-
centration of these metabolites (Ruhfus and Kinne 1996). 
Muscle was the only organ that displayed decreased ura-
cil concentration in response to thawing. The plasma and 
the remaining organs demonstrated markedly increased 
uracil concentrations. The reason for the decrease in ura-
cil concentration in muscle is not yet fully understood.
The effects of thawing on the plasma metabolome: evaluating differences between thawed plasma…
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5  Conclusions
The main aim of this study was to investigate the effects 
of thawing on the metabolic profiles of different sam-
ple types (i.e. gut, kidney, liver, muscle, pancreas and 
plasma). The comparison between thawed organ and 
plasma samples indicated that the organ samples were 
much more sensitive to thawing. The majority of identi-
fied metabolites were altered in response to thawing in all 
five organ groups. These included amino acids, carbohy-
drates, fatty acids, lipids and nucleic acids. Cholic acid, 
galacturonic acid, 3-hydroxybutyric acid, phosphoric acid 
and pyroglutamic acid were the only metabolites found 
to be stable in the organ tissues. Discrepancies between 
organs may have been attributed to differences in cellular 
protection, biocomposition and enzymatic availability.
Although the metabolic profile of plasma was also 
altered dramatically in response to thawing (with 
increased levels of amino acids, fatty acids, glycerol 
metabolites and purine and pyrimidine metabolites), a 
number of metabolites were found to remain at stable 
levels. These included several amino acids (glutamine, 
glycine, isoleucine, leucine, taurine and valine) and TCA 
cycle intermediates (citric acid, fumaric acid, lactic acid 
and malic acid). In certain circumstances, plasma sam-
ples must be thawed, aliquoted and distributed to multi-
ple sites for different analyses. In these cases the use of 
repeatedly thawed plasma may be unavoidable. Although 
caution should be taken when using these samples for 
metabolic profiling studies, in this study, we have shown 
that the use of thawed plasma can be acceptable for the 
measurement of specific metabolites, which remain stable 
in response to thawing.
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